Pfizer (PFE) Goodwill (2016 - 2025)
Historic Goodwill for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $69.1 billion.
- Pfizer's Goodwill rose 77.44% to $69.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $69.1 billion, marking a year-over-year increase of 77.44%. This contributed to the annual value of $68.5 billion for FY2024, which is 109.76% up from last year.
- Latest data reveals that Pfizer reported Goodwill of $69.1 billion as of Q3 2025, which was up 77.44% from $69.0 billion recorded in Q2 2025.
- Over the past 5 years, Pfizer's Goodwill peaked at $69.3 billion during Q1 2024, and registered a low of $49.2 billion during Q4 2021.
- Moreover, its 5-year median value for Goodwill was $51.5 billion (2023), whereas its average is $58.1 billion.
- Per our database at Business Quant, Pfizer's Goodwill crashed by 1738.34% in 2021 and then soared by 3462.0% in 2024.
- Over the past 5 years, Pfizer's Goodwill (Quarter) stood at $49.2 billion in 2021, then increased by 4.4% to $51.4 billion in 2022, then surged by 31.94% to $67.8 billion in 2023, then rose by 1.1% to $68.5 billion in 2024, then increased by 0.84% to $69.1 billion in 2025.
- Its Goodwill stands at $69.1 billion for Q3 2025, versus $69.0 billion for Q2 2025 and $68.4 billion for Q1 2025.